<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03583632</url>
  </required_header>
  <id_info>
    <org_study_id>ERM 1year follow-up</org_study_id>
    <nct_id>NCT03583632</nct_id>
  </id_info>
  <brief_title>Visual Acuity and Optical Coherence Tomography One Year After Peeling of Epiretinal Membranes</brief_title>
  <official_title>Visual Acuity and Optical Coherence Tomography One Year After Peeling of Epiretinal Membranes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vienna Institute for Research in Ocular Surgery</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vienna Institute for Research in Ocular Surgery</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Improvement in visual acuity and retinal anatomy one year after surgery is assessed and
      compared to data preoperative and 3 months after surgery
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Improvement in visual acuity and retinal anatomy (documented by optical coherence tomography)
      one year after surgery is assessed and compared to data preoperative and 3 months after
      surgery. Aim of the study is to examine possible improvements of surgical outcomes in the
      period up to the one year follow-up.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>visual acuity</measure>
    <time_frame>3 minutes</time_frame>
    <description>visual acuity testing with EDTRS charts</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>optical coherence tomography</measure>
    <time_frame>3 minutes</time_frame>
    <description>optical coherence tomography generates slides of the retinal anatomy with light</description>
  </secondary_outcome>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Epiretinal Membrane</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>visual acuity testing</intervention_name>
    <description>testing of visual ycuity by ETDRS charts</description>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>optical coherence tomography</intervention_name>
    <description>optical coherence tomography generates sectional slides of the retinal tomography with light</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        For this study only patients after vitrectomy with Membrane Peeling due to epiretinal
        membranes are selected
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  vitrectomy with Membrane Peeling due to an epiretinal membrane

        Exclusion Criteria:

          -  none
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Oliver Findl, MD, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>VIROS at Hanuschkrankenhaus Vienna</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Oliver Findl, MD, Prof</last_name>
    <phone>+43 1 91021-84611</phone>
    <email>oliver@findl.at</email>
  </overall_contact>
  <location>
    <facility>
      <name>Vienna Institute for Research in Ocular Surgery (VIROS), Hanusch Hospital Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1140</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Oliver Findl, MD, Prof</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>June 28, 2018</study_first_submitted>
  <study_first_submitted_qc>June 28, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 11, 2018</study_first_posted>
  <last_update_submitted>October 21, 2019</last_update_submitted>
  <last_update_submitted_qc>October 21, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 22, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vienna Institute for Research in Ocular Surgery</investigator_affiliation>
    <investigator_full_name>Prim. Prof. Dr. Oliver Findl, MBA</investigator_full_name>
    <investigator_title>Head of the Department of Ophthalmology, Professor, Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epiretinal Membrane</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

